tiprankstipranks
Trending News
More News >
Integrated BioPharma Inc (INBP)
OTHER OTC:INBP
US Market

Integrated BioPharma (INBP) Income Statement

Compare
8 Followers

Integrated BioPharma Income Statement

Last quarter (Q1 2026), Integrated BioPharma's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, Integrated BioPharma's net income was $123.00K. See Integrated BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 54.35M$ 50.32M$ 50.67M$ 56.25M$ 63.56M
Gross Profit
$ 5.56M$ 3.88M$ 4.06M$ 6.55M$ 9.48M
Operating Expenses
$ 3.54M$ 3.63M$ 3.94M$ 3.81M$ 3.70M
Depreciation and Amortization
$ 1.27M$ 1.22M$ 1.15M$ 834.00K$ 826.00K
EBITDA
$ 3.38M$ 1.47M$ 1.27M$ 3.56M$ 6.61M
Operating Income
$ 2.02M$ 251.00K$ 120.00K$ 1.97M$ 5.78M
Other Income/Expenses
$ 42.00K$ 17.00K$ -20.00K$ -148.00K$ 1.46M
Pretax Income
$ 2.06M$ 268.00K$ 100.00K$ 2.60M$ 7.25M
Net Income
$ 808.00K$ 112.00K$ -34.00K$ 3.84M$ 8.01M
Per Share Metrics
Basic EPS
$ 0.03$ 0.00$ 0.00$ 0.13$ 0.27
Diluted EPS
$ 0.03$ 0.00$ 0.00$ 0.12$ 0.25
Weighted Average Shares Outstanding
30.30M 30.07M 29.95M 29.84M 29.70M
Weighted Average Shares Outstanding (Diluted)
31.17M 30.87M 29.95M 32.32M 32.11M
Currency in USD

Integrated BioPharma Earnings and Revenue History